FOCAL CME organizes the FOCAL Therapy Course, an educational meeting focused on focal and partial-gland treatments for prostate cancer and related urologic care. Its 2026 program offers an annual meeting agenda, courses, faculty presentations, and continuing medical education information, with in-person and virtual registration options for physicians, trainees, physician assistants and nurse practitioners, and industry participants.

The course addresses candidate selection, clinical evidence, cancer-control and functional outcomes, post-treatment surveillance, and the prevention and management of complications. Its curriculum also covers transperineal interventions, treatment planning across different modalities, minimally invasive procedures for benign prostatic hyperplasia, genetic testing, and management of advanced prostate cancer, including recurrence and metastatic disease. Additional topics include radiation for oligometastatic disease and systemic therapies for metastatic castration-resistant prostate cancer.

A featured course introduces irreversible electroporation and the NanoKnife System, covering foundational principles, patient selection, and clinical outcomes, with a focus on two-year PRESERVE outcomes and real-world insights. FOCAL CME also provides meeting logistics, accreditation resources, and registration support. The event is managed by Veritas Association Management.